Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Movement Disorders

• Publication date

  2009-05-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.22534PMID 19353591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of olfactory dysfunction with risk for future Parkinson's disease

  2008cited by this paper
• A comparative study of odor identification and odor discrimination deficits in Parkinson's disease

  2008cited by this paper
• Different odor tests contribute differently to the evaluation of olfactory loss.

  2008cited by this paper
• Olfactory Dysfunction in Parkinson’s Disease

  2007cited by this paper
• Olfactory loss may be a first sign of idiopathic Parkinson's disease

  2007cited by this paper
• Association of olfactory dysfunction with incidental Lewy bodies

  2006cited by this paper
• Smell identification ability in twin pairs discordant for Parkinson's disease

  2005cited by this paper
• Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

  2004cited by this paper
• Idiopathic hyposmia as a preclinical sign of Parkinson's disease

  2004cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Deficits on Corsi's block-tapping task in early stage Parkinson's disease.

  2003cited by this paper
• Functional anatomy of human odor sensation, discrimination, and identification in health and aging.

  2003cited by this paper
• Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis

  2001cited by this paper
• Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

  2001influential reference
• Motor perseveration is an early sign of Parkinson’s disease

  2001cited by this paper
• Olfactory functions are mediated by parallel and hierarchical processing.

  2000cited by this paper
• Odor discrimination and task duration in young and older adults.

  2000cited by this paper
• Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson’s disease

  1999cited by this paper
• Abnormal performance on the PD test battery by asymptomatic first-degree relatives

  1999cited by this paper
• Movement Disorders

  1998cited by this paper
• Olfactory dysfunction in Parkinson's disease.

  1997cited by this paper
• Olfactory dysfunction in familial parkinsonism

  1997cited by this paper
• Development of the 12‐Item Cross‐Cultural Smell Identification Test(CC‐SIT)

  1996cited by this paper
• Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.

  1995cited by this paper
• Tests of human olfactory function: Principal components analysis suggests that most measure a common source of variance

  1994cited by this paper
• Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

  1992cited by this paper
• Cognitive function in Parkinson's disease: from description to theory.

  1990cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Olfactory dysfunction in parkinsonism

  1988cited by this paper
• Influence of intertrial interval and sniff-bottle volume on phenyl ethyl alcohol odor detection thresholds

  1986cited by this paper

• Cognitive changes preceding Parkinson's disease: a systematic review and meta-analysis of prospective population-based studies

  2025cites this paper
• Marine Bioactive Components and Chronic Neuroinflammation: Focus on Neurodegenerative Disease

  2025cites this paper
• Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults.

  2025cites this paper
• The impact of olfactory loss on quality of life: a 2025 review

  2025cites this paper
• Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease

  2025cites this paper
• Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression

  2024cites this paper
• Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses.

  2023cites this paper
• Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s Disease

  2022influential citation
• Desarrollo de una prueba de identificación de olores de amplia disponibilidad

  2022cites this paper
• Parkinson's Disease: Risk Factor Modification and Prevention

  2022cites this paper
• Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease

  2022cites this paper
• Association between Functional Connectivity of Entorhinal Cortex and Olfactory Performance in Parkinson’s Disease

  2022cites this paper
• [Analysis of clinical characteristics in the patient with olfactory disorders].

  2022cites this paper
• Olfaction and Executive Cognitive Performance: A Systematic Review

  2022cites this paper
• Cognition in prodromal Parkinson's disease.

  2022cites this paper
• Olfactory-trigeminal interactions in patients with Parkinson's disease.

  2021cites this paper
• Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

  2021cites this paper
• Acute Systemic Experimental Inflammation Does Not Reduce Human Odor Identification Performance

  2021cites this paper
• Towards subgroup-specific risk estimates: A meta-analysis of longitudinal studies on olfactory dysfunction and risk of Parkinson's disease.

  2021cites this paper
• Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis

  2021influential citation
• Olfactory Loss and Aging: Connections with Health and Wellbeing.

  2021cites this paper
• Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson’s Disease

  2021cites this paper
• Clinical Trials for Disease-Modifying Agents in Parkinson’s Disease

  2021cites this paper
• Nonmotor problems in Parkinson disease

  2021cites this paper
• Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study

  2020cites this paper
• Parkinson’s Disease Affects Functional Connectivity within the Olfactory-Trigeminal Network

  2020cites this paper
• POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research

  2020cites this paper
• Approaches to the Early Diagnosis of Parkinson’s Disease

  2020cites this paper
• for Disease-Modifying Agents in Parkinson’s

  2020cites this paper
• Olfaction in Parkinson’s Disease – A Clinical Approach

  2020cites this paper
• MT2 melatonin receptors expressed in the olfactory bulb modulate depressive-like behavior and olfaction in the 6-OHDA model of Parkinson's disease.

  2020cites this paper
• Microbiota and Parkinson's disease (overview)

  2020cites this paper
• Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease

  2020cites this paper
• [Approaches to early diagnosis of Parkinson's disease].

  2019cites this paper
• Hyposmia as a Predictive Marker of Parkinson's Disease: A Systematic Review and Meta-Analysis

  2019cites this paper
• Higher probability of prodromal Parkinson disease is related to lower cognitive performance

  2019cites this paper
• The effect of docosahexaenoic acid on apelin distribution of nervous system in the experimental mouse model of Parkinson's disease.

  2019cites this paper
• Clinical Assessment of Olfactory Disorders

  2019cites this paper
• The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease

  2019cites this paper
• Machine-learning-derived rules set excludes risk of Parkinson’s disease in patients with olfactory or gustatory symptoms with high accuracy

  2019cites this paper
• Specific intranasal and central trigeminal electrophysiological responses in Parkinson’s disease

  2019cites this paper
• The importance of preclinical diagnostics in Parkinson disease.

  2019cites this paper
• Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease

  2018cites this paper
• Vyšetření čichu u neurologických onemocnění pomocí Testu parfémovaných fixů Olfactory Testing in Neurological Diseases using Odourized Markers Test

  2018cites this paper
• Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss

  2018cites this paper
• When Do &agr;-Synucleinopathies Start? An Epidemiological Timeline: A Review

  2018cites this paper
• Olfactory dysfunction and cognition among older adults in the United States

  2018cites this paper
• Evaluation of idiopathic olfactory loss with chemosensory event‐related potentials and magnetic resonance imaging

  2018cites this paper
• Risk stratification and targeted neuroprotection in Parkinson disease utilising the glucocerebrosidase pathway

  2018cites this paper
• Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease

  2018cites this paper
• Cognition among individuals along a spectrum of increased risk for Parkinson’s disease

  2018cites this paper
• Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression

  2018cites this paper
• Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease

  2017cites this paper
• Biomarkers of Nonmotor Symptoms in Parkinson's Disease.

  2017cites this paper
• Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease

  2017cites this paper
• Spotlight on olfactory dysfunction in Parkinson's disease

  2017cites this paper
• The gut‐brain axis in Parkinson's disease: Possibilities for food‐based therapies

  2017cites this paper
• Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet

  2017cites this paper
• Cognition and the course of prodromal Parkinson's disease

  2017cites this paper
• Targeting the Gut-Brain axis in Parkinson's disease

  2017cites this paper
• Nicotine from cigarette smoking and diet and Parkinson disease: a review

  2017cites this paper
• Chapter 21 – The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease

  2017cites this paper
• The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system

  2017cites this paper
• Olfactory Bulb Volume Changes in Patients With Nasal Septal Deviation

  2017cites this paper
• Cognitive changes in prodromal Parkinson's disease: A review

  2017cites this paper
• Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease?

  2017cites this paper
• Movement disorders Prodromal symptoms of Parkinson ’ s disease : Implications for epidemiological studies of disease etiology Symptômes prodromiques dans la maladie de Parkinson : implications pour les études épidémiologiques de l ’ étiologie de la maladie

  2016cites this paper
• Advances in markers of prodromal Parkinson disease

  2016cites this paper
• Biomarkers in Prodromal Parkinson Disease: a Qualitative Review

  2016cites this paper
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cites this paper
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cites this paper
• Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology.

  2016cites this paper
• Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease

  2016cites this paper
• Transkranieller Ultraschall und dreidimensionale Bewegungsanalyse zur Identifikation einer Risikogruppe für Morbus Parkinson

  2015cites this paper
• Criteria for Prodromal Parkinson ’ s Disease

  2015cites this paper
• Assessing Olfactory Function in Parkinson's Disease via Entropy Analysis of Chemosensory Event Related Potentials.

  2015cites this paper
• MDS research criteria for prodromal Parkinson's disease

  2015cites this paper
• [Identification of people at the latent stage of Parkinson's disease (the PARKINLAR study): first results and an optimization of the algorithm].

  2015cites this paper
• Quantitative Tests des statischen Gleichgewichts in der Prodromalphase des Parkinson-Syndroms

  2015cites this paper
• Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers

  2014cites this paper
• The role of alpha-synuclein phosphorylation in synucleinopathies

  2014cites this paper
• High-resolution CISS MR imaging with and without contrast for evaluation of the upper cranial nerves: segmental anatomy and selected pathologic conditions of the cisternal through extraforaminal segments.

  2014cites this paper
• Novel psychophysical and electrophysiological tools to assess human olfactory function and evaluation of their potential for an early diagnosis of Alzheimer’s disease

  2014cites this paper
• 6 Combinations of Markers Provide Clues to the Underlying Neurodegenerative Disorder in REM Sleep Behavior Disorder

  2014cites this paper
• Premotor and nonmotor features of Parkinson's disease.

  2014cites this paper
• A Clinical Approach Towards Smell Loss in Parkinson's Disease

  2014cites this paper
• Glucocerebrosidase mutations and Parkinson's disease

  2013cites this paper
• CONTINUING EDUCATION PROGRAM : FOCUS . . . The olfactory system

  2013cites this paper
• The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease

  2013cites this paper
• Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

  2013cites this paper
• Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years.

  2013cites this paper
• Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein

  2013cites this paper
• Executive dysfunction in Parkinson's disease: a review.

  2013cites this paper
• Long term compulsivity on the 5-choice serial reaction time task after acute Chlorpyrifos exposure.

  2013cites this paper
• Neuroanatomical correlates of olfactory loss in normal aged subjects.

  2013cites this paper
• Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications

  2013cites this paper
• EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease

  2013cites this paper
• Le système olfactif

  2013cites this paper
• The olfactory system.

  2013cites this paper
• Nonmotor Symptoms of Parkinson's Disease

  2012cites this paper